NCT03386331 is a NA clinical trial of diet and exercise in Overweight, sponsored by Diabetes Foundation, India.

Who is sponsoring NCT03386331?

NCT03386331 is sponsored by Diabetes Foundation, India.

What drugs are being tested in NCT03386331?

Interventions in NCT03386331: diet and exercise.

What condition does NCT03386331 study?

NCT03386331 studies Overweight, Obesity.

Is NCT03386331 still recruiting?

NCT03386331 is currently completed. Last updated 4 February 2021.

Last reviewed 2021-02-04 · How we verify

NCT03386331

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VDR Gene Polymorphisms and Weight Loss in Non-diabetic Overweight and Obese Subjects

Completed NA Last updated 4 February 2021

What this trial tests

NA trial testing diet and exercise in Overweight in 110 participants. Completed in 30 March 2019.

Timeline

16 March 2016

Primary endpoint
30 March 2019

30 March 2019

Quick facts

Lead sponsor	Diabetes Foundation, India
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	110
Start date	16 March 2016
Primary completion	30 March 2019
Estimated completion	30 March 2019
Sites	1 location across India

Drugs / interventions tested

diet and exercise

Conditions studied

Overweight — all drugs for Overweight →
Obesity — all drugs for Obesity →

Sponsor

Diabetes Foundation, India

Who can join

Adults 20 to 60, any sex, with Overweight or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a six months intervention study in non-diabetic overweight and obese subjects. Subjects will be counseled for weight loss through diet and exercise. Diet and exercise will be recommended as per the regular norms for weight loss (weight loss ≥10% from baseline weight will be considered as a significant loss of weight) for overweight and obese subjects. A sample size of 90 subjects was calculated but assuming a drop out rate of 20%, 110 subjects will be enrolled. Enrolled subjects will be measured at every visit (monthly) for weight, body composition measures of abdominal obesity and skin folds. They would be assessed for compliance with diet and exercise. Detailed analysis of body composition including DXA, biochemical analysis will be performed at enrollment and after six months intervention. Statistical analysis will be performed to find association between measures of body composition for weight loss and genotypes of the VDR polymorphisms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of diet and exercise

Trials testing the same drug.

NCT04161703 — Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease · NA · completed

Other recruiting trials for Overweight

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting

Other Diabetes Foundation, India trials

Trials by the same sponsor.

NCT07205705 — Impact of Partially Replacing Wheat With Millets or Bengal Gram Flour in Rotis on Glycemia and Prediabetes Reversal · NA · not yet recruiting
NCT06454773 — To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood · Phase 3 · recruiting
NCT06386939 — Comparison of Micro- and Macrovascular Disease(s) in People With T2D, Who Have Moderate to Severe Acanthosis Nigricans v · recruiting
NCT06386952 — To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump · recruiting
NCT05925946 — Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03386331 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Diabetes Foundation, India
Last refreshed: 4 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03386331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing